Project Grant R01HD118728
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded Children's Research Institute a $768,372 Project Grant on September 4, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds the Tracking Adverse Prenatal Brain Stressors on Offspring Development (TABS) study, which will deliver comprehensive longitudinal research services examining the neurobiological impacts of maternal...
- Federal Grant Award Summary The National Institute of Child Health and Human Development (NICHD) awarded a $163,050 Project Grant to the University of Chicago on November 22, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award extends through June 30, 2029, and supports a research initiative titled "Leveraging Enhanced Phenotyping and Causal Inference Approaches to Investigate the Effect of Maternal Medication Exposures on Child...
- Summary of Federal Project Grant Award The National Institute of Child Health and Human Development (NICHD) awarded $844,250 to the University of Nebraska Medical Center (UNMC) under the Child Health and Human Development Extramural Research program (CFDA 93.865) on July 1, 2025, for a two-year project period concluding June 30, 2027. The research initiative addresses critical gaps in understanding potential neurodevelopmental harms caused by antiretroviral (ARV) exposure in utero among the...
- Federal Grant Award Summary Children's Research Institute received a $654,005 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded June 1, 2026, with a completion date of March 31, 2031. This research initiative investigates the function of the paralaminar nucleus of the amygdala (PL) during the critical developmental transition from adolescence to early adulthood. The project will deliver scientific knowledge...
- Federal Project Grant Award Summary The University of California, San Diego received a $663,493 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 4, 2026, with a completion date of March 31, 2031. This research initiative investigates the immune cell-placenta-serotonin axis in peripartum depression (PPD) and selective serotonin reuptake inhibitor (SSRI)...
- Federal Grant Award Summary The University of Houston System received a $846,528 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded September 5, 2025, with completion targeted for August 31, 2027. This research project utilizes a large electronic health record database spanning 12 years to characterize the effects of selective serotonin reuptake inhibitors...
- Federal Project Grant Award Summary New York University School of Medicine received a $245,782 Project Grant award effective February 1, 2026, through January 31, 2029, from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The research investigates how maternal immune activation (MIA)—a significant prenatal insult associated with preterm birth and neurodevelopmental disorders—alters...
- Federal Grant Award Summary The Children's Research Institute received a $500,500 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2025, through May 31, 2027. The award funds the development of quantitative electroencephalogram (EEG) biomarkers for Smith-Magenis Syndrome (SMS), a rare neurodevelopmental disorder caused by deletion or mutation of the...
- Federal Project Grant Award Summary The Eunice Kennedy Shriver National Institute of Child Health and Human Development awarded $249,000 to the Icahn School of Medicine at Mount Sinai under the Child Health and Human Development Extramural Research program (CFDA 93.865) on March 1, 2026, with a completion date of February 28, 2029. This R00 Pathway to Independence Award establishes an independent research program for a tenure-track faculty member within the Departments of Psychiatry and...
- Federal Grant Award Summary Oregon Health & Science University received a $151,626 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective September 1, 2025, with completion expected June 22, 2027. This award supports research on early identification of neurodevelopmental disorders through in utero magnetic resonance imaging (MRI). The project leverages a longitudinal dataset of 229 serially imaged pre- and...
The Children's Research Institute received a $794,699 Project Grant from the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded on June 18, 2026, with completion targeted for February 28, 2031. The research initiative, titled "Maternal Depression and Antidepressant Effects on Fetal Brain Structure and Function (FABMOMS)," focuses on evaluating the separate and interactive effects of in utero antidepressant exposure and maternal Major Depressive Disorder (MDD) on fetal and infant brain structure and function, with specific emphasis on the hippocampus. The project delivers research products and scientific services through the application of novel quantitative Magnetic Resonance Imaging (QMRI) tools and maternal heart rate variability assessment techniques. These sophisticated methodologies are employed to explore associations between prenatal exposure to serotonin reuptake inhibitors (SRI), maternal stress, and psychiatric symptoms on fetal and neonatal neurodevelopment. This research addresses a critical gap in understanding neurobehavioral development of children exposed to antidepressant medications in utero, utilizing advanced study designs and analytic approaches to distinguish the effects of pharmacological exposure from the underlying psychiatric disease and its associated physiological and psychosocial consequences. The work represents a rigorous scientific investigation within the broader context of maternal and child health research funded through the NIH's extramural research program.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $794.7k | 6/19/26 |